Related Experiment Video

Updated: Aug 4, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

[The mutagenic and carcinogenic activity of chemical compounds]

V N Rakitskiĭ, V S Turusov

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |April 28, 2005
    PubMed

    Insights

    Mutagenicity tests detect DNA-damaging genotoxic carcinogens but miss non-genotoxic carcinogens. Long-term rodent studies are essential for reliable carcinogenicity detection of chemical substances.

    Area of Science:

    • Toxicology
    • Chemical Carcinogenesis
    • Genetics

    Context:

    • Chemicals can be mutagenic (damaging DNA) or carcinogenic (causing cancer).
    • Understanding the relationship between mutagenicity and carcinogenicity is crucial for risk assessment.
    • Genotoxic carcinogens interact with DNA, while non-genotoxic carcinogens act through other mechanisms like promotion or cytotoxicity.

    Purpose:

    • To analyze the association between mutagenicity and carcinogenicity of chemical compounds.
    • To differentiate between genotoxic and non-genotoxic carcinogen detection methods.
    • To establish reliable methods for carcinogenicity assessment.

    Summary:

    • Genotoxic carcinogens are identified by mutagenicity tests due to their DNA interaction.
    • Non-genotoxic carcinogens' mechanisms include promotion, cytotoxicity, and oxidative stress, which are not detected by mutagenicity tests.
    • Mutagenicity tests are insufficient for determining carcinogenicity; long-term rodent bioassays are the sole reliable method.

    Impact:

    • Highlights the limitations of mutagenicity testing in chemical safety evaluation.
    • Emphasizes the necessity of long-term rodent studies for accurate carcinogenicity assessment.
    • Informs regulatory strategies for chemical risk management and toxicological testing protocols.

    More Related Videos

    Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

    Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

    Published on: March 20, 2018

    The Lambda Select cII Mutation Detection System07:08

    The Lambda Select cII Mutation Detection System

    Published on: April 26, 2018

    Related Concept Videos

    Mutations01:39

    Mutations

    Overview
    Mutations01:35

    Mutations

    Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
    Chromosomal Alterations Are Large-Scale Mutations
    While point mutations are changes in a single nucleotide in...
    Types of Toxins01:36

    Types of Toxins

    Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
    Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
    Environmental pollutants like...
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    Bioactivation and Tissue Toxicity01:25

    Bioactivation and Tissue Toxicity

    Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
    Spontaneous and Induced Mutations01:30

    Spontaneous and Induced Mutations

    Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).